Medtronic to buy SPR Therapeutics for about $650M

Medtronic to buy SPR Therapeutics for about $650M is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Elise Reuter · 2026-05-20

Medtronic would gain a treatment for chronic pain management in its third major acquisition this year.

Source: MedTech Dive